We report that a two-site model proved superior, indicating approximately equal low and high binding components in healthy controls, but a lower fraction of high affinity anti-α-synuclein NAbs in PD patients, and a near absence of the high affinity component in plasma from MSA patients. Here, SNCA is linked to multiple system atrophy.